Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q2 2024 · 10-Q
Revenue$53.17M$53.17M−9.5% vs Q2 2023 Net Income-$1.23M-$1.23MN/M vs Q2 2023 EPS Diluted-$0.23-$0.23N/M vs Q2 2023 Gross Profit$32,109,000−11.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$9,776,000−7.4% Free Cash Flowderived$9,142,000+2.5% Margins · derivedGross margin60.4%−1.5 pt vs Q2 2023
Operating margin-0.1%−6.9 pt vs Q2 2023
Net margin-2.3%−4.5 pt vs Q2 2023
ended Sep 30, 2023 · filed Nov 6, 2023 · 37 d after period end